Fitness guru and heart attack survivor amps up AZ campaign with meet-and-greets

Former Biggest Loser coach Bob Harper
Former "The Biggest Loser" host Bob Harper is hitting the road this summer in a extension of the AstraZeneca survivors' awareness campaign. (AstraZeneca)

Fitness coach and heart attack survivor Bob Harper told his story last year to inspire fellow heart patients to share their own. Now, the star of AstraZeneca’s “Survivors Have Heart” awareness push is hitting the road to meet other survivors in person.

AstraZeneca expanded the initial campaign to include in-person events with Harper after positive and inspiring feedback poured in last year. And the patients' stories spurred AZ to launch MySurvivorStory.com online, where heart attack survivors can discuss their journeys and vie for a chance to meet Harper at a local event. Harper's national tour kicked off in Tampa June 5.

For those who can’t attend an event, the new “Survivors Have Heart” Facebook community aims to help survivors share their personal stories and connect with one another. One of the key goals of the initial campaign, validated by patient feedback, was to raise awareness about the psychological impact of heart attacks.

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

RELATED: AstraZeneca taps Biggest Loser host Bob Harper for heart attack survivors push

“As we have heard from courageous survivors, the emotional journey can be sometimes even more challenging [than the initial physical recovery]," Alex Dyer, AstraZeneca's executive director of cardiovascular marketing, said via email.

"The cardiovascular risk for having another heart attack remains long after having the initial heart attack itself," Dyer noted, "so ‘Survivors Have Heart’ aims to offer heart attack survivors an inspiring and engaging community, so they don't have to go through this often overwhelming and sometimes isolating experience alone,”

RELATED: AstraZeneca's Brilinta wins in diabetic artery disease patients

AstraZeneca initially connected with Harper, a former host of “The Biggest Loser” TV show, after discovering that he'd been prescribed the company's clot-fighting drug Brilinta as part of his recovery plan.

AZ notched Brilinta sales of $1.3 billion in 2018, a 22% jump over 2017, and attributed (PDF) growth to continued penetration in acute coronary syndrome patients and high-risk heart attack survivors. More recently, Brilinta aced a combination study with aspirin in reducing the risk of heart attack, stroke and cardiovascular death in patients with Type 2 diabetes with coronary artery disease who hadn’t suffered prior heart attack or stroke.

Suggested Articles

The second of AbbVie’s highly anticipated 2019 blockbuster candidates is here: Its crucial Humira follow-up, Rinvoq.

Bristol-Myers Squibb’s takeover of Celgene hasn’t always gone smoothly, but now a once-left-for-dead centerpiece of that deal is ready to launch.

Investors sued Novo Nordisk in Denmark, claiming it misled the public about trouble plaguing its insulin franchise—and demanding $1.75B in damages.